Shire plc Director Declaration
December 21 2018 - 11:30AM
Dow Jones News
TIDMSHP
Director Declaration
December 21, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company")
announces that Ian Clark, Non-Executive Director of the Company, is a
Non-Executive Director of Guardant Health, Inc which became publically
quoted on October 4, 2018.
This disclosure is made pursuant to LR 9.6.14 of the UK Listing Rules.
Sarah Rixon
Senior Company Secretarial Assistant
For further information please contact:
Investor Relations
Christoph Brackmann christoph.brackmann@shire.com +41 41 288 41 29
Sun Kim sun.kim@shire.com +1 617 588 8175
Scott Burrows scott.burrows@shire.com +41 41 288 4195
Media
Katie Joyce kjoyce@shire.com +1 781 482 2779
NOTES TO EDITORS
About Shire
Shire is the global biotechnology leader serving patients with rare
diseases and specialized conditions. We seek to push boundaries through
discovering and delivering new possibilities for patient communities who
often have few or no other champions. Relentlessly on the edge of what's
next, we are serial innovators with a diverse pipeline offering fresh
thinking and new hope. Serving patients and partnering with healthcare
communities in over 100 countries, we strive to be part of the entire
patient journey to enable earlier diagnosis, raise standards of care,
accelerate access to treatment, and support patients. Our diverse
portfolio of therapeutic areas includes Immunology, Hematology, Genetic
Diseases, Neuroscience, Internal Medicine, and Ophthalmics.
Championing patients is our call to action - it brings the opportunity -
and responsibility - to change people's lives.
www.shire.com
(END) Dow Jones Newswires
December 21, 2018 11:15 ET (16:15 GMT)
Copyright (c) 2018 Dow Jones & Company, Inc.
Shire (NASDAQ:SHPGY)
Historical Stock Chart
From Jul 2024 to Aug 2024
Shire (NASDAQ:SHPGY)
Historical Stock Chart
From Aug 2023 to Aug 2024